Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here is one profitable company that leverages its financial strength to beat the competition and two best left off your watchlist.
Two Stocks to Sell:
Park-Ohio (PKOH)
Trailing 12-Month GAAP Operating Margin: 5.2%
Based in Cleveland, Park-Ohio (NASDAQ: PKOH) provides supply chain management services, capital equipment, and manufactured components.
Why Should You Dump PKOH?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 1.8% annually over the last two years
- High input costs result in an inferior gross margin of 15.5% that must be offset through higher volumes
- Cash-burning history makes us doubt the long-term viability of its business model
Park-Ohio’s stock price of $22.06 implies a valuation ratio of 7x forward P/E. Check out our free in-depth research report to learn more about why PKOH doesn’t pass our bar.
Charles River Laboratories (CRL)
Trailing 12-Month GAAP Operating Margin: 3.5%
Named after the Massachusetts river where it was founded in 1947, Charles River Laboratories (NYSE: CRL) provides non-clinical drug development services, research models, and manufacturing support to pharmaceutical and biotechnology companies.
Why Do We Think Twice About CRL?
- Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
- Projected sales for the next 12 months are flat and suggest demand will be subdued
- Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results
Charles River Laboratories is trading at $186.63 per share, or 17.5x forward P/E. To fully understand why you should be careful with CRL, check out our full research report (it’s free for active Edge members).
One Stock to Buy:
Euronet Worldwide (EEFT)
Trailing 12-Month GAAP Operating Margin: 13.2%
Operating a global network of over 47,000 ATMs and 821,000 point-of-sale terminals across more than 60 countries, Euronet Worldwide (NASDAQ: EEFT) provides electronic payment solutions including ATM services, prepaid product processing, and international money transfer services.
Why Should You Buy EEFT?
- Annual revenue growth of 11.1% over the last five years beat the sector average and underscores the unique value of its offerings
- Performance over the past five years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
- Industry-leading 19.5% return on equity demonstrates management’s skill in finding high-return investments
At $73.37 per share, Euronet Worldwide trades at 6.9x forward P/E. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free for active Edge members .
High-Quality Stocks for All Market Conditions
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
